The study examined changes in the use of antiepileptic drugs (AEDs) in a large hospital for people with a learning disability over a 2 year period, the use of investigations, and the presence of medication side-effects. The surveys were carried out in 1993 and 1995/6. In 1993, 27% of patients were being treated for epilepsy and in 1995/6, 30.1%. Ninety percent and 82.4% of patients, respectively, were receiving one or two AEDs. In the second survey there were fewer prescriptions for phenobarbitone (5.8% vs. 12.5%) and an increase in the use of lamotrigine (21.6% vs. 5%), gabapentin (5.8% vs. 0) and vigabatrin (3.9% vs. 2.5% in 1993). Side-effects were recorded in 6 (11.8%) patients. Seven (21.2%) patients receiving carbamazepine were found to have hyponatraemia. Of the 54 electroencephalograms (EEGs) requested, 41 (76%) were reported as abnormal. Six CT brain scans had been conducted, of which five were abnormal. People receiving antipsychotic drugs had fewer seizures than average.
Introduction
Compared to the general population, epilepsy is more prevalent among the learning disabled. It may also be more difficult to manage. Assessment and management strategies are similar to those used for the nondisabled population, but they may have to be modified to take account of communication problems, the presence of additional disabilities or disorders and the use of other medications. Recognized practices in epilepsy management include the use of EEGs to confirm the diagnosis or to distinguish genuine seizures from nonepileptic seizures, tics or motor stereotypies. As in the general population, video recording of suspected seizures can supplement this. Computed tomography can also be used to assist aetiological diagnosis and to document changes 1 . For confirmed epilepsy, control with monotherapy is the ideal, although many new antiepileptic drugs (AEDs) are initially licensed only for 'add on' therapy. An appropriate AED is selected depending on the type of seizures or syndrome identified. Seizure frequency can be monitored using diaries (or charts in hospital patients). Regular observation for any obvious AED side-effects is important. Monitoring of AED serum levels can also be carried out, and is of particular value for some compounds such as phenytoin and carbamazepine. For other agents (such as valproate), the measurement of serum concentrations is irrelevant unless a lack of compliance or toxicity is suspected.
Over the past 20 years AED prescribing patterns have changed. It has been recognized that the older AEDs (phenobarbitone, primidone and phenytoin) have an adverse effect on cognitive function even when serum concentrations are within the therapeutic range 2 . In addition, the recognition that polypharmacy is more likely than monotherapy to cause cognitive impairment (as well as increasing the likelihood of side-effects) led to a push towards monotherapy 3 . This view is now being challenged, as research unravels the mode of action of AEDs, raising the possibility of 'rational polypharmacy' combining compounds with different or complementary modes of action.
There have been many studies looking at epilepsy in the learning disabled. In his survey of disabled children in Camberwell, Corbett (1975) found that a third of severely retarded children had suffered seizures at some time and a fifth had experienced at least one seizure in the previous year. He and others have also shown that the prevalence of epilepsy increases with the severity of learning disability [4] [5] [6] .
Other studies have looked at prescribing patterns of AEDs in the learning disabled. Some studies have involved audits of hospital populations [7] [8] [9] or community samples 10 . Other studies have looked at populations of people with epilepsy and a learning disability and monitored them over a period of time with the aim of reducing AED prescribing. These studies have shown that polytherapy can often be reduced without worsening seizure control [11] [12] [13] .
The previous studies have tended to focus on AED prescribing and seizure frequency without taking other relevant factors into account. These include investigation results, side-effects (including blood abnormalities) and the possible effects of other drugs prescribed. The present study involved a survey of AED prescribing in a population of people with a learning disability and epilepsy. The aims were: (a) to assess the use of the older vs. the newer AEDs; (b) to assess the prevalence of side-effects of the AEDs; (c) to look at the possible effects of other drugs prescribed and other diagnoses; and (d) to compare the findings to those in a previous survey of the same population.
Materials and Methods
Monyhull Hospital is a large Learning Disability hospital in South Birmingham. In 1993, and again in 1997, all inpatients who were being treated for epilepsy with AEDs were identified. A retrospective case-note analysis was undertaken. Information collected included age, sex, severity of learning disability, cause of primary handicap, co-existing medical or psychiatric illnesses, previous investigations, AEDs prescribed, seizure frequency over the period and the types of seizures recorded.
The 1993 survey examined prescribing over a 3 month period. The 1997 survey was of a 2 year period (1/1/95 to 31/12/96). Additional information collected in the latter survey included the age of the patient at the onset of the epilepsy, notes made of side-effects from the AEDs, abnormal blood results, other medication prescribed and any changes in AED type or dose.
The data were analysed using SPSS version 7.5.
Results
In December 1995 there were 123 patients in Monyhull Hospital. Of these, 37 (30.1%) were being treated for epilepsy. A further 14 patients receiving respite care at the hospital had epilepsy and were included in the study. Of the 51 patients studied, 33 (64.7%) were male and 18 (35.3%) were female. Their ages ranged from 20 to 92 years (mean 45.2 years). Eight (16%) patients had a mild learning disability, 5 (10%) moderate, 32 (63%) severe and 6 (12%) had a profound learning disability. The causes of the patients' learning disabilities are summarized in Table 1 .
Other diagnoses and treatments
Eleven patients (21.6%) had an additional psychiatric or developmental disorder and 38 (74.5%) had one or more additional physical disorders. Tables 2 and 3 summarize the diagnoses. Forty people (78.4%) were receiving other medications, of which 17 (33.3%) were antipsychotics, 16 (31.3%) were bowel medications and 29 (56.9%) were other types of drugs. Eleven people (21.6%) were receiving three or more additional drugs.
Epilepsy
The age at which the diagnosis of epilepsy was confirmed was known in 35 patients, and varied from 0.1 to 70 years (mean 11.2 years). Twenty-one (41.2%) patients were classified as having generalized seizures (tonic-clonic, tonic, clonic, absence and myoclonic) with 18 suffering from tonic-clonic seizures only. Three patients (5.9%) had partial seizures with or without secondary generalization. Twenty-seven people (52.9%) had epilepsy that was unclassified or had multiple seizure types. Eighteen of the latter had a severe or profound learning disability.
Seven seizures charts were missing from the notes and could not, therefore, be included in the results. In addition, 14 patients were admitted for respite only. For six of the 14, although seizures had been monitored in hospital, no home-kept diaries were available. Seizures recorded per annum varied from 0 to 134 in the first year (mean 12.2) and 0 to 169 in the second year (mean 17.8). The majority of patients had well-controlled epilepsy, with 11 (21.6%) suffering no seizures in the 2 year period and 26 (51%) having an average of two or fewer seizures per month.
Antipsychotic medication and severity of learning disability
People receiving antipsychotic medication had an average of 15.3 seizures over the 2 years, compared to the average for the group as a whole of 30 seizures over 2 years. Those patients with a severe or profound learning disability had an average of 34.8 seizures.
Anticonvulsant drugs
Twenty-three (45.1%) patients were receiving one AED only, 17 (33.3%) were receiving two, 8 (15.7%) were receiving three drugs and 3 (5.9%) were receiving four AEDs. Table 4 shows the AEDs prescribed, and those used as the sole agent. Four (7.8%) patients were receiving dosages of AED which were above the BNF recommended level.
Thirteen (25.5%) patients were receiving one of the older AEDs (phenobarbitone, phenytoin or primidone). Their ages ranged from 20 to 92 years with an average of 59.8 years. Four (30.8%) of these had had no seizures in the previous 2 years, and one person had only had one seizure. Two out of these five had undergone reductions in their AED and another patient's AED had been successfully stopped. Sixteen (31.4%) patients were receiving one of the newer AEDs (lamotrigine, gabapentin, vigabatrin). In six patients, lamotrigine had been commenced because of uncontrolled seizures. In one patient it was started as the sole AED and the patient became seizure free. In the other five patients it was started as an adjunct to other AEDs. In two of these, the seizures reduced in frequency. In another two, no change was recorded. In the sixth patient it was later stopped due to lack of effect.
Gabapentin was started in four respite patients. In one, a note was made of a reduced frequency of seizures. In two cases there were no recorded changes in seizure frequency. In the fourth patient, the gabapentin was commenced too late in the study period for any effect to be recorded. Gabapentin was the fourth AED in three cases and the third in one case. Both of the vigabatrin prescriptions had been commenced prior to the study period.
Side-effects reported in the notes included ataxic gait in 2 (3.9%), falls in 1(2%) and hirsutism in 1(2%). These four reports were all from patients receiving sodium valproate. Also reported were prolonged rashes in 2 (3.9%) people receiving carbamazepine and gabapentin, lethargy associated with phenytoin and dizziness with lamotrigine. There was also one report of confusion, ataxic gait, lethargy and anorexia with carbamazepine, the patient also having hyponatraemia.
Investigations
Twenty (39%) patients had never had an EEG. One EEG had been performed for 18 (35%) of the patients, two EEGs for 7 (14%), three EEGs for 4 (7.8%) and four or more EEGs for 2 (4%) patients. Out of the 54 EEGs which had been performed, 13 were reported as normal and 41 (76%) as abnormal.
Forty-five (98%) patients had never had a CT brain scan. Out of the six reported CTs, 5 (83%) detected abnormalities.
A total of 26 abnormal blood results were reported for the 51 patients. Seven (14%) patients had a report of hyponatraemia (with sodium values ranging from 123 to 131 mmol/1). Two of these had an associated low calcium level. In all cases the patient was receiving carbamazepine. Conversely, 21.2% of patients receiving carbamazepine had a report of hyponatraemia.
Anaemia was reported in 10 (19%) patients, macrocytosis in 2 (4%), neutropenia in 4 (8%) and raised alkaline phosphatase in 2 (4%).
Twenty-three (45.1%) patients had at least one reported serum AED level taken for one or both of the 12 month periods. Dosage changes were made in 8 (16%) of these as a result of abnormal serum levels.
Comparison with 1993 Survey (1995/96 results are written in parentheses)
The population resident at Monyhull Hospital in December 1993 comprised 148 patients. Forty or 27% (30.1%) of these were receiving AED medication. The proportions of people with different severities of learning disability were as follows: mild in 30% (16%), moderate in 37.5% (10%), severe in 17.5% (63%) and profound in 5% (12%). Out of all the patients taking AEDs, 52.5% (21.6%) had an additional psychiatric disorder.
Ninety percent (41.2%) of patients were classified as suffering from generalized seizures, 5% (5.9%) from partial seizures with or without secondary generalization and 5% (52.9%) from multiple seizure types or were unclassified. Seizure control was very similar for the two surveys with 25% (21.6%) seizure free in 1993 and 55% (51%) having two or less seizures per month. Table 4 shows the percentages of patients prescribed each of the AEDs in 1993. Ninety percent of patients were receiving one or two AEDs compared to 82.4% in 1995/96. Serum AED levels had been taken in 87.5% (45.1%) of patients.
There were no EEG reports for 27.5% (39%) of patients. Full blood counts had been taken in 85% of patients and biochemistry (U&Es/LFTs) in 57.5%.
Discussion
Our study was conducted on two occasions, comparing a survey of 1993 vs. 1995/96 results of patients prescribed AEDs in a Learning Disability hospital. At the time of these surveys, the hospital population studied was undergoing a process of resettlement. This probably explains some of the differences. For example, there were higher numbers of patients with epilepsy and more with severe learning disability in 1995/6 compared to 1993. The proportions remain similar if the respite patients included in the second survey are excluded (74% with a severe or profound learning disability overall in 1995/6 and 69.7% in long stay patients alone).
Our findings for the proportion of patients in a Learning Disability hospital population with epilepsy (27% and 30.1%) are similar to those reported in other studies 7, 12 . Over 90% of the seizures were generalized or multiple seizures, which is higher than that found in other studies 6 . However, it is difficult to be certain of the accuracy of the classification. There were several charts with both complex partial and absence seizures recorded. It may be that staff are confusing the two. In addition, seizures classed as tonic-clonic could in some cases have been partial with secondary generalization. There is also a marked difference between the two surveys in the number of people suffering from multiple seizure types/unclassified (5% compared to 52.9% in 1993) as well as generalized seizures (41.2% compared to 90% in 1993). These differences, again, may be due to inaccurate recording. The results of the survey by Singh and Towle 9 suggest that the 1993 records may be more accurate. They looked at 100 community charts of patients with a learning disability and found that patients with a more severe level of learning disability tended to have a more mixed pattern of seizures.
Our finding of over a third of patients receiving antipsychotic drugs is in keeping with Fishbacher's result. His survey in 1987 of prescribing in a Mental Handicap hospital found that a third of all the patients were taking an antipsychotic drug 8 . Surprisingly, despite the known epileptogenic tendencies of antipsychotic drugs, this latter group in our study had an average seizure frequency which was lower than for the group as a whole. This is in keeping with the finding by Brodtkorb et al. in 1993 who found a negative correlation between seizure activity and neuroleptic dosage in a group of institutionalized mentally retarded patients 14 .
Less than half of the patients were receiving monotherapy. In addition, the numbers receiving one or two AEDs dropped from 90% to 82.4% in the interval between the two surveys. A similar two-point survey of a Learning Disability hospital by Amaladoss 9 found that the percentage of patients on one or two AEDs dropped from 80% to 66% despite implementation of quality standards after the first survey. Other studies have shown figures of around 60% of people being treated with monotherapy 7, 8, 10, 12 . However, most of these studies did not indicate the severity of the epilepsy. In Collacott's study 12 , 37% were seizure free compared to our 21.6%, and 52% suffered less than one seizure per year compared to our 31.4%. This indicates that our population had less well-controlled seizures and this is probably a feature of the change in the hospital population as already described. In addition, at the time of the study the newer AEDs were licensed solely as 'add on' therapies. Their increased use between the two surveys would, therefore, possibly distort the picture. A similar picture emerged in the study by Amaladoss 9 who found an increase in patients on three or more drugs. In these cases one of the newer AEDs had been added to the regime.
Over a quarter of the patients were on one of the older AEDs, with patients as young as 20 years receiving such prescriptions. However, the number of prescriptions for all of the older AEDs except primidone fell between 1993 and 1995. In contrast, the number of prescriptions for the newer AEDs increased over this period. Gabapentin having not been prescribed at all in 1993 was being used in 95/96 for more intractable cases and in a quarter of these a reduced frequency of seizures was reported. One patient (17%) on lamotrigine became seizure free and a third had a reduced frequency. Bhaumik et al. in 1997 looked at the prescribing of vigabatrin, lamotrigine and gabapentin in consultant caseloads of patients with a learning disability 14 . They found that no patients became seizure free on lamotrigine but that over a third underwent a greater than 50% reduction in seizure frequency. Over half experienced the same reduction with gabapentin. One patient (17%) on lamotrigine in our study had to discontinue due to lack of effect compared to over a quarter in Bhaumik et al.'s group.
Regarding investigations, it is often a challenging task to perform EEGs and CT scans on people with a learning disability. However, our results show that a high proportion of abnormalities are picked up (75% of EEGs and 83% of CT scans). Whether this helped in the management of the epilepsy is not clear.
Blood tests, however, being a more amenable investigation, could possibly be performed too frequently and for insufficient reason. We found a high proportion of abnormal blood results. Nearly a fifth of the patients were anaemic. Over a quarter had other blood abnormalities which indicated AED side-effects. Particularly notable of these is the high proportion of people taking carbamazepine who had hyponatraemia (21.2%). There are no similar studies to compare with in this instance. Critchlow 15 in 1998 looked at a population of psychiatric patients and found five out of 19 with hyponatraemia were taking carbamazepine. Amaladoss 9 found hyponatraemia in six patients (8%) but no mention was made of which AED they were receiving.
With regard to AED serum levels, our results showed that over a third of patients who had their serum levels checked had an AED dosage change as a consequence of the level. A study by Jackson et al. in 1994 looking at a population with epilepsy in a Learning Disability hospital, found that serum levels for AEDs other than phenobarbitone appeared to fluctuate considerably for unexplained reasons 17 . They concluded that one serum level is insufficient evidence on which to base an alteration in AED dose.
This study highlights the information that can be gathered by a survey of a learning disabled population, especially where changes over time can be evaluated. Reductions in the number and dose of AEDs may be facilitated by such an audit of seizure frequency, seizure type and AED side-effects. With the move into the community, a proportion of this population may be cared for by staff who lack experience in seizure identification. Our findings suggest that even among trained staff, identification is difficult. Educational input directed at identifying seizures and AED side-effects would be one strategy to improve epilepsy management.
Limitations of our study included the fact that the majority were institutional residents, and a large proportion had a severe learning disability. They were not, therefore, a representative sample and the numbers audited were relatively small. The study was retrospective, and was therefore limited by the quality of the information recorded. Unfortunately, owing to the small numbers and the short study period no firm conclusions can be drawn regarding the use of the newer AEDs in the learning disabled. This is clearly an area in which more work needs to be done. In addition, for this particular population, a further survey following their move into the community would be useful and is being planned.
